GPCR

Structure Therapeutics Inc. - ADR

89.88

USD

GPCR Earnings Reports

Positive Surprise Ratio

GPCR beat 1 of 12 last estimates.

Next Report

Date of Next Report

Feb 25, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.39

Implied change from Q3 25 (Revenue/ EPS)

+5.41%

Implied change from Q4 24 (Revenue/ EPS)

-43.48%

Structure Therapeutics Inc. - ADR earnings per share and revenue

On Nov 06, 2025, GPCR reported earnings of -0.37 USD per share (EPS) for Q3 25, missing the estimate of -0.35 USD, resulting in a -3.24% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.88% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 16 analysts forecast an EPS of -0.39 USD, with revenue projected to reach -- USD, implying an increase of 5.41% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Twist Bioscience Corporation Common Stock

Report Date

Feb 02, 2026 For Q1 26

Estimate

-$0.43

Actual

-$0.50

Surprise

-14.00%

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

FAQ

What were Structure Therapeutics Inc. - ADR's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Structure Therapeutics Inc. - ADR reported EPS of -$0.37, missing estimates by -3.24%, and revenue of $0.00, 0% as expectations.

How did the market react to Structure Therapeutics Inc. - ADR's Q3 2025 earnings?

The stock price moved down -1.88%, changed from $33.47 before the earnings release to $32.84 the day after.

When is Structure Therapeutics Inc. - ADR expected to report next?

The next earning report is scheduled for Feb 25, 2026.

What are the forecasts for Structure Therapeutics Inc. - ADR's next earnings report?

Based on 16 analysts, Structure Therapeutics Inc. - ADR is expected to report EPS of -$0.39 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.